Every February, Black History Month, the U.S. honors the contributions and sacrifices of African Americans who have helped shaped our nation's history.

BrainStorm looks at the future through a societal lens as the US population transitions to minority majority. 

The Centers for Medicare and Medicaid Services (CMS), the federal health insurance program for people 65 plus, announced its decision to deny covering Biogen’s Aduhelm and all future anti-amyloid treatments under what is known as a Coverage with Evidence Development (CED).